Loading company details...
Latest Form 4 (Sep 16, 2026): Eric Weinberg (Chief Business Development Officer): Exercise/Conversion of 35,168 shares, $152.6K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 16, 2026 | Eric Weinberg, Chief Business Development Officer | Exercise/Conversion | 35,168 | $152.6K |
| Sep 10, 2026 | Mark Wilterding, Chief Financial Officer | Disposition to Issuer | 258,770 | n/a |
| Sep 10, 2026 | Eric Weinberg, Chief Business Development Officer | Disposition to Issuer | 87,437 | n/a |
| Sep 10, 2026 | Ronald M. Kurtz Md., Chief Medical Officer | Disposition to Issuer | 338,819 | n/a |
| Sep 10, 2026 | Ilya Goldshleger, Chief Operating Officer | Disposition to Issuer | 98,367 | n/a |
| Sep 3, 2026 | Ronald M. Kurtz Md., Chief Medical Officer | Exercise/Conversion | 13,425 | n/a |
| Sep 3, 2026 | Mark Wilterding, Chief Financial Officer | Exercise/Conversion | 20,441 | n/a |
| Sep 3, 2026 | Ilya Goldshleger, Chief Operating Officer | Exercise/Conversion | 5,370 | n/a |
| Sep 3, 2026 | Eric Weinberg, Chief Business Development Officer | Exercise/Conversion | 5,370 | n/a |
| Jul 25, 2026 | Aziz Mottiwala, President and CEO | Grant/Award | 2,312,138 | n/a |